Status:
COMPLETED
The Effects of Two Different Intravenous Lipid Emulsions on the Outcomes of Preterm Infants With Sepsis
Lead Sponsor:
Mansoura University Children Hospital
Conditions:
Sepsis Newborn
Eligibility:
All Genders
1-28 years
Phase:
PHASE4
Brief Summary
Introduction and objectives: Lipid emulsions play an important role in parenteral nutrition in preterm infants. We aim to evaluate the effect of two different intravenous lipid emulsions on the outcom...
Detailed Description
1. Introduction Neonatal sepsis is a clinical syndrome of bacteremia with systemic symptoms and signs of infection in the first 28 days of life. In recent national studies, the incidence of suspected ...
Eligibility Criteria
Inclusion
- Gestational age of 28 to less than 37 weeks who showed clinical symptoms and signs suggestive of early-onset sepsis (EOS, within 72 hours of birth) or late-onset sepsis (LOS, after 72 hours of birth) and received PN.
Exclusion
- Neonates with
- Major congenital malformations
- Congenital heart diseases
- Inborn errors of metabolism
- Congenital infections
- Hypoxic-ischemic encephalopathy
Key Trial Info
Start Date :
February 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2017
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03275090
Start Date
February 1 2016
End Date
February 1 2017
Last Update
March 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University Children Hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35516